Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: comparative analysis with three DNA-based assays.
Ilie MI, Lassalle S, Long-Mira E, Bonnetaud C, Bordone O, Lespinet V, Lamy A, Sabourin JC, Haudebourg J, Butori C, Guevara N, Peyrottes I, Sadoul JL, Bozec A, Santini J, Capper D, von Deimling A, Emile JF, Hofman V, Hofman P. Ilie MI, et al. Among authors: lespinet v. Thyroid. 2014 May;24(5):858-66. doi: 10.1089/thy.2013.0302. Epub 2014 Mar 6. Thyroid. 2014. PMID: 24417277
Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France).
Long E, Ilie M, Lassalle S, Butori C, Poissonnet G, Washetine K, Mouroux J, Lespinet V, Lacour JP, Taly V, Laurent-Puig P, Bahadoran P, Hofman V, Hofman P. Long E, et al. Among authors: lespinet v. J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2436-43. doi: 10.1111/jdv.13332. Epub 2015 Sep 16. J Eur Acad Dermatol Venereol. 2015. PMID: 26377147
NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?
Falk AT, Heeke S, Hofman V, Lespinet V, Ribeyre C, Bordone O, Poudenx M, Otto J, Garnier G, Castelnau O, Guigay J, Leroy S, Marquette CH, Hofman P, Ilié M. Falk AT, et al. Among authors: lespinet v. Expert Rev Anticancer Ther. 2017 Aug;17(8):681-685. doi: 10.1080/14737140.2017.1331736. Epub 2017 May 22. Expert Rev Anticancer Ther. 2017. PMID: 28511612
Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer.
Ilie M, Butori C, Lassalle S, Heeke S, Piton N, Sabourin JC, Tanga V, Washetine K, Long-Mira E, Maitre P, Yazbeck N, Bordone O, Lespinet V, Leroy S, Cohen C, Mouroux J, Marquette CH, Hofman V, Hofman P. Ilie M, et al. Among authors: lespinet v. Oncotarget. 2017 Oct 4;8(61):103055-103062. doi: 10.18632/oncotarget.21476. eCollection 2017 Nov 28. Oncotarget. 2017. PMID: 29262544 Free PMC article.
Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients.
Heeke S, Hofman V, Long-Mira E, Lespinet V, Lalvée S, Bordone O, Ribeyre C, Tanga V, Benzaquen J, Leroy S, Cohen C, Mouroux J, Marquette CH, Ilié M, Hofman P. Heeke S, et al. Among authors: lespinet v. Cancers (Basel). 2018 Mar 21;10(4):88. doi: 10.3390/cancers10040088. Cancers (Basel). 2018. PMID: 29561830 Free PMC article.
In-house Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-small Cell Lung Cancer and Melanoma Patients.
Heeke S, Benzaquen J, Long-Mira E, Audelan B, Lespinet V, Bordone O, Lalvée S, Zahaf K, Poudenx M, Humbert O, Montaudié H, Dugourd PM, Chassang M, Passeron T, Delingette H, Marquette CH, Hofman V, Stenzinger A, Ilié M, Hofman P. Heeke S, et al. Among authors: lespinet v. Cancers (Basel). 2019 Aug 29;11(9):1271. doi: 10.3390/cancers11091271. Cancers (Basel). 2019. PMID: 31470674 Free PMC article.
Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution.
Heeke S, Hofman V, Ilié M, Allegra M, Lespinet V, Bordone O, Benzaquen J, Boutros J, Poudenx M, Lalvée S, Tanga V, Salacroup C, Bonnetaud C, Marquette CH, Hofman P. Heeke S, et al. Among authors: lespinet v. J Transl Med. 2020 Feb 17;18(1):87. doi: 10.1186/s12967-020-02259-2. J Transl Med. 2020. PMID: 32066459 Free PMC article.
Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France).
Lassalle S, Hofman V, Heeke S, Benzaquen J, Long E, Poudenx M, Lantéri E, Boutros J, Tanga V, Zahaf K, Lalvée S, Lespinet V, Bordone O, Félix JM, Bonnetaud C, Marquette C, Ilie M, Hofman P. Lassalle S, et al. Among authors: lespinet v. Cancers (Basel). 2020 Apr 13;12(4):955. doi: 10.3390/cancers12040955. Cancers (Basel). 2020. PMID: 32294880 Free PMC article.
Real-world assessment of the BRAF status in non-squamous cell lung carcinoma using VE1 immunohistochemistry: A single laboratory experience (LPCE, Nice, France).
Hofman V, Benzaquen J, Heeke S, Lassalle S, Poudenx M, Long E, Lantéri E, Bordone O, Lespinet V, Tanga V, Bonnetaud C, Bille Y, Ilié M, Marquette C, Barlesi F, Boutros J, Hofman P. Hofman V, et al. Among authors: lespinet v. Lung Cancer. 2020 Jul;145:58-62. doi: 10.1016/j.lungcan.2020.04.024. Epub 2020 May 5. Lung Cancer. 2020. PMID: 32408133 Free article.
28 results